Showing results (51-60 of 152) with videos related to

Sort By:
Pageof 16
Journal of the National Cancer Institute|April 19, 2007
Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancerMaurizio Scaltriti, Federico Rojo, Alberto Ocaña, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 29, 2003
Is there a benefit by the sequence anastrozole-formestane for postmenopausal metastatic breast cancer women?Paolo Carlini, Gianluigi Ferretti, Serena Di Cosimo, et al.
British Journal of Cancer|November 28, 2018
Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefitTiziana Triulzi, Viola Regondi, Loris De Cecco, et al.
Anticancer Research|July 15, 2009
Biological and clinical features in predicting efficacy of epidermal growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysisMarina Chiara Garassino, Karen Borgonovo, Antonio Rossi, et al.
Breast Cancer (Tokyo, Japan)|January 7, 2017
Complete remission in metastatic breast cancer: expecting the unexpected-results of a cross-sectional studyGiulia Galli, Anna Tessari, Luca Porcu, et al.
Seminars in Cancer Biology|October 19, 2019
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cellsCarolina Reduzzi, Marta Vismara, Lorenzo Gerratana, et al.
Tumori|March 23, 2016
Axillary coverage by whole breast irradiation in 1 to 2 positive sentinel lymph nodes in breast cancer patientsMaria Carmen De Santis, Francesca Bonfantini, Michela Dispinzieri, et al.
ESMO Open|May 23, 2020
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast CancerEvandro de Azambuja, Dario Trapani, Sibylle Loibl, et al.
Cancer|August 4, 2005
Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary treeAlain Gelibter, Paola Malaguti, Serena Di Cosimo, et al.
Scientific Reports|January 28, 2022
Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancerMarco Silvestri, Matteo Dugo, Marta Vismara, et al.
Pageof 16